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Abstract
Exercise is recommended by public health agencies for weight management; however, the role of 
exercise is generally considered secondary to energy restriction. Few studies exist that have 
verified completion of exercise, measured the energy expenditure of exercise, and prescribed 
exercise with equivalent energy expenditure across individuals and genders.
Objective—The objective of this study was to evaluate aerobic exercise, without energy 
restriction, on weight loss in sedentary overweight and obese men and women.
Design and Methods—This investigation was a randomized, controlled, efficacy trial in 141 
overweight and obese participants (body mass index, 31.0 ± 4.6 kg/m2; age 22.6 ± 3.9 years). 
Participants were randomized (2:2:1 ratio) to exercise at either 400 kcal/session or 600 kcal/
session or to a non-exercise control. Exercise was supervised, 5 days/week, for 10 months. All 
participants were instructed to maintain usual ad libitum diets. Due to the efficacy design, 
completion of ≥ 90% of exercise sessions was an a priori definition of per protocol, and these 
participants were included in the analysis.
Results—Weight loss from baseline to 10 months for the 400 and 600 kcal/session groups was 
3.9 ± 4.9kg (4.3%) and 5.2 ± 5.6kg (5.7%), respectively compared to weight gain for controls of 
0.5 ± 3.5kg (0.5%) (p<0.05). Differences for weight loss from baseline to 10 months between the 
exercise groups and differences between men and women within groups were not statistically 
significant.
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Conclusions—Supervised exercise, with equivalent energy expenditure, results in clinically 
significant weight loss with no significant difference between men and women.
Introduction
The prevalence of overweight (BMI ≥ 25.0) and obesity (BMI ≥ 30.0) among US adults is 
~68% and 34%, respectively.1 Overweight and obesity contribute to heart disease, 
hypertension, diabetes, and some cancers as well as psychosocial and economic 
difficulties.2-5 Exercise is recommended for weight management by virtually every public 
health organization6-10; however, the role of exercise is generally considered secondary to 
energy restriction for the treatment of obesity.11-13 The secondary role for exercise may be 
due to the absence of studies that verify the completion of exercise, measure the energy 
expenditure of exercise (EEEx), and prescribe the exercise to have equivalent EEEx across 
individuals and genders. Measurement of EEEx and verification of exercise completion are 
essential components of any study to adequately evaluate the impact of exercise on weight 
loss.
The Midwest Exercise Trial-2 (MET-2) was an adequately powered, properly designed, 10 
month efficacy trial to evaluate the role of supervised exercise without energy restriction on 
weight loss in a sample of overweight and obese young adult men and women to address the 
following aims:
1. Does exercise without energy restriction result in clinically significant weight 
change across groups from baseline to 10 months?
2. Do men and women have equivalent changes in weight in response to exercise 
completed at equivalent levels of EEEx?
Methods and Procedures
Design
A detailed description of the rationale and design for MET-2 has been published.14 One 
hundred forty one overweight or obese individuals, age 18-30 years, with a BMI between 
25-40 kg/m2 were randomized to an exercise intervention (EEEx = 400 or 600 kcal/session) 
or non-exercise control condition. Exercise sessions were completed 5 days/week for 10 
months, were supervised, and EEEx was assessed monthly by indirect calorimetry. All 
participants were instructed to maintain their baseline diet and physical activity patterns over 
the 10 month study. Participants who did not complete ≥90% of scheduled exercise sessions 
at the assigned level of EEEx and all outcome assessments, were dismissed from the study. 
Ninety two participants (46 men/46 women) were compliant with the study protocol and are 
included in the analysis presented herein. The primary outcomes were body weight and body 
composition. Secondary outcomes of maximal aerobic capacity, energy and macronutrient 
intake, and daily physical activity are presented briefly and detailed procedures have been 
published.14 With the exception of EEEx all assessments were identical for the exercise and 
control groups. All participants provided written informed consent prior to participating and 
were compensated at a rate of $7.87/hour for an average total of 254 hours for participation 
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in physical activity and testing throughout the study. Approval for this study was obtained 
from the Human Subjects Committee at the University of Kansas-Lawrence.
Participant inclusion/exclusion
Participants were men and women (BMI 25-40 kg/m2, age 18 to 30 years) who were able to 
exercise and willing to be randomized. Participants were excluded for the following reasons: 
A history of chronic disease (i.e., diabetes, heart disease, etc.), elevated blood pressure 
(>140/90), lipids (cholesterol >6.72 mmol/L; triglycerides >5.65 mmol/L), fasting glucose 
(>7.8 mmol/L), use of tobacco products, medications affecting physical performance (e.g., 
beta blockers), or metabolism (e.g., thyroid, steroids), inability to perform laboratory tests or 
moderate-to-vigorous exercise, and planned physical activity greater than 500 kcal/week.15
Randomization and blinding
Participants were stratified by gender and randomized by an independent statistician under 
the supervision of the project statistician (MSM) in a 2:2:1 ratio to 400 and 600 kcal/session 
and control, respectively (Figure 1). Blinding of participants to group assignment was not 
possible. Investigators and research assistants were blinded at the level of outcome 
assessments, data entry and data analysis.
Exercise Intervention
We evaluated two levels of EEEx at 400 and 600 kcal/session, 5 days/week. These levels of 
EEEx are consistent with recommendations from The American College of Sports Medicine 
Position Stand “Appropriate Physical Activity Intervention Strategies for Weight Loss and 
Prevention of Weight Regain for Adults”.11 Exercise was primarily walking/jogging on 
motor-driven treadmills; however, to provide variety and decrease overuse injuries, alternate 
activities were allowed for 20% of the exercise sessions. Exercise progressed from 150 kcal/
session at intervention onset to the target EEEx of 400 or 600 kcal/session at the end of 
month 4 and remained at target for the final 6 months of the study (Table 1).
Energy expenditure of exercise (EEEx)
Detailed information regarding prescription of exercise has been reported elsewhere.14 
Briefly, participants were provided with the duration of exercise sessions required to achieve 
the prescribed level of EEEx. The duration was provided by results from indirect 
calorimetry (ParvoMedics TrueOne2400, ParvoMedics Inc., Sandy, UT) whereby the EEEx 
was measured at 70% and 80% of maximal heart rate. The resulting kcal/min was used to 
calculate the minutes necessary to achieve the desired EEEx and this procedure was 
conducted at baseline and repeated monthly with adjustments to the treadmill speed, grade 
and duration as necessary. For example: EEEx = 9.2 kcal/minute, prescribed exercise = 400 
kcal/session, exercise duration = 400/9.2 = 44 minutes/session.
Exercise compliance and supervision
Exercise was supervised by trained research staff and the duration and intensity of all 
exercise sessions were verified by a heart rate monitor (RS 400; Polar Electro Inc, 
Woodbury, NY). Compliance was considered as successfully completing ≥ 90% of exercise 
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sessions. Participants who were non compliant during any 3 month interval (months 0-3, 
3-6, and 6-9) or during the final month of the study (month 10) were dismissed.
Assessments—Outcome assessments for analyses were completed at baseline and 10 
months by trained research assistants. The details of these procedures have been published 
elsewhere.14
Weight and body composition
Weight was measured between 7 and 10 a.m. using a scale accurate to ±0.1 kg (PS6600, 
Befour Inc., Saukville, WI). Participants were weighed prior to breakfast and wore a 
standardized hospital gown. Dual energy x-ray absorptiometry (DXA) was used to 
determine fat-free mass, fat mass, and percent body fat (Lunar DPX-IQ). Women completed 
pregnancy testing prior to each DXA test.
Aerobic capacity
Maximal aerobic capacity was assessed on a motor-driven treadmill using a modified Balke 
protocol.16 The test was considered valid if participants meet three of four criteria: 1) heart 
rate ±10 beats·min-1 of the age-predicted maximal heart rate, 2) rating of perceived exertion 
greater than 17, 3) respiratory exchange ratio greater than 1.10, and 4) oxygen consumption 
plateau.
Energy intake/macronutrient composition
Energy intake and macronutrient composition was assessed over a 7-day period, 4 times 
over the course of the study during ad libitum eating in The University of Kansas cafeteria. 
Digital photographs were obtained before and after consumption and the type and amount of 
foods and beverages consumed were quantified by trained research staff.17,18 Food 
consumed outside the cafeteria was assessed with multiple pass 24-hour recall procedures. 
Food and beverage consumption were entered into Nutrition Data System for Research 
(University of Minnesota, Minneapolis, MN v. 2006) for determination of total energy and 
macronutrient content.
Physical activity
Daily physical activity outside the exercise program was documented using a portable 
accelerometer (ActiGraph Model GT1M; Actigraph, LLC, Pensacola, FL). Participants wore 
the ActiGraph on a belt over the non-dominant hip for 7 consecutive days at baseline, 3, 6 
and 10 months. Data were analyzed for daily physical activity using a custom software 
program.
Sample size
Sample size was determined to provide adequate statistical power for the analysis of aims 1 
and 2. Aim 1 compared weight change (10-months baseline) across the three groups. From 
our previous work,19 we expected participants randomized to the control arm to gain weight 
(~5%), the 400 kcal/session group to remain weight stable, and participants in the 600 kcal/
session group to lose weight (~5%). In our previous studies the 5% gain and 5% loss were 
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equivalent to an average change of approximately 0.5 standard deviations. Given these 
assumptions, and a conservative rate of attrition of 33%, 136 participants were needed to be 
randomized to the 400 kcal/session and 600 kcal/session groups and a control group in a 
2:2:1 ratio to insure a total sample of 90. A sample of 90 completers provided 88% power to 
detect the hypothesized difference across the groups using a one-way analysis of variance 
with a type I error rate of 5%. Aim 2 determined if the change in weight (10-months 
baseline) was equivalent between males and females for both the 400 and 600 kcal/session 
groups, respectively. Equivalence was defined as a ratio of the average weight change in 
males versus females between 0.85 and 1.15. Previous data from MET-1indicated that the 
coefficient of variation (standard deviation/mean) is 0.10 for change in weight at 10 
months.19 Given these assumptions, 18 males and 18 females were necessary to determine if 
the ratio of the means was equivalent with 95% power assuming a type I error rate of 0.025. 
Each statistical test was conducted at two levels of exercise, therefore we used a type I error 
rate of 0.025 for each test.
Statistical Analyses—Baseline demographic and outcome variables were summarized by 
means and standard deviations. Based upon the design, we first examined if weight loss, 
BMI, fat mass, body fat percentage, and fat-free mass were equivalent between men and 
women in the 400 and 600 kcal/session groups. These variables were found not equivalent 
thus gender, which was a stratification variable, was examined as a potential factor related to 
the primary and all secondary outcomes using a two factor analysis of variance with 
treatment and gender as main effects and the interaction effect between gender and 
treatment. The test for interaction was completed first, and if not significant, tests for main 
effects were performed. All interaction and main effects were tested at the 0.05 level of 
significance. Since there were three treatment groups, if a treatment main effect was seen for 
an outcome, pairwise comparison using Tukey's HSD adjustment was used to determine 
which treatment groups differed from one another. This investigation was an efficacy study; 
therefore, all analyses were only conducted on subjects who were compliant and completed 
the 10 month intervention. No form of imputation was necessary or performed for the 
analysis presented in this manuscript. All analyses were performed in SAS Software v9.2.
Results
Participants
One hundred forty one individuals were initially randomized to exercise or control and 92 
individuals (65.2%) complied with the study protocol and completed all outcome 
assessments (Figure 1). The baseline characteristics of the 92 completers are shown in Table 
2. There were no significant differences in baseline characteristics between the 3 study 
groups or between participants initially randomized (n =141) and completers (n = 92) with 
the exception of maximal aerobic capacity.
Exercise compliance
Attendance at exercise sessions did not differ by exercise group (400 kcal/session = 91.9 ± 
2.9%, 600 kcal/session = 91.3 ± 3.0 %) or by gender (men = 91.4 ± 3.0%, women = 91.7 ± 
2.6%). The average target heart rate for the exercise groups for months 4-10 was 150.6 ± 
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11.6 beats·min-1 while the actual exercise heart rate averaged 150.8 ± 11.7 beats·min-1. The 
average EEEx from month 4-10 for the 400 and 600 kcal/session groups was 402 ± 6 and 
604 ± 7 kcal/session, respectively. EEEx did not differ between men and women assigned to 
either of the exercise groups. Women required 48 ± 7 min/session and 63 ± 9 min/session to 
complete the 400 kcal and 600 kcal prescriptions, respectively. Men required 31 ± 6 min/
session and 42 ± 8 min/session to achieve the 400 and 600 kcal prescriptions, respectively.
Body weight/composition
Weight change over the 10 month intervention in both the 400 (-3.9 ± 4.9; 4.3%) and 600 
(-5.2 ± 5.6 kg; 5.7%) kcal/session groups was significantly different than control [(0.5 ± 3.5 
kg; 0.5%); Table 3]; however, weight change between exercise groups did not differ 
significantly. There were no significant differences for weight change between men and 
women in either the 400 (men: -3.8 ± 5.8 kg; 3.7%; women = -4.1 ± 4.2 kg; 4.9%) or 600 
kcal/session groups (men: -5.9 ± 6.7 kg; 5.9%; women = -4.4 ± 2.1 kg; 5.4%). Although not 
significantly different, weight loss for men in the 600 kcal/session group was 2.1 kg greater 
than for the 400 kcal/session group. Weight loss in women in the 600 kcal/session group 
was only 0.3 kg greater than the 400 kcal/session group.
Figure 2 presents individual data for percent weight change by group. In the 600 kcal/
session group 62.2% of participants achieved weight loss ≥ 5% of baseline weight compared 
with 45.9% in the 400 kcal/session group. In the 600 kcal/session group 55.6% of women 
and 68.4% of men achieved ≥ 5% of baseline weight loss compared with 47.4% of women 
and 44.5% of men in the 400 kcal/session group (Figure 3). Forty four percent of 
participants in the control group gained weight compared to 27% in the 400 and 19% in the 
600 kcal/session groups.
At 10 months, the mean change in fat mass was significantly different from baseline in both 
the 400 kcal/session (-3.5 ± 4.8 kg,) and 600 kcal/session groups (-5.2 ± 5.2 kg), but not in 
controls (+0.2 ± 3.2 kg). The reduction in fat mass in the 400 and 600 kcal/session groups 
was significantly different from control but it was not significantly different between 
exercise groups. There were no significant differences for change in fat mass between men 
and women in either the 400 (men: -3.6 ± 5.3 kg, women: -3.4 ± 4.6 kg) or 600 (men: -5.9 ± 
6.0 kg, women: -4.4 ± 4.3 kg) kcal/session groups.
Significant changes in percent body fat over 10 months were observed in both the 400 (-2.9 
± 3.9 %) and 600 (-4.4 ± 4.4 %) kcal/session groups. Percent fat was unchanged in the 
control group (-0.6 ± 2.4 %). The change in percent fat was significantly greater in the 600 
kcal/session group compared with the control group but did not differ between the 400 kcal/
session and control groups or between the 400 and 600 kcal/session groups. The reductions 
in body weight observed in both exercise groups were a result of decreased fat mass and 
preservation or increase in fat-free mass (Figure 4). At 10 months, there were significant 
differences between the control group and both the 400 and 600 kcal/session groups for total 
weight and fat mass. The reduction in total weight and fat mass in the 400 and 600 kcal/
session groups was not significantly different between exercise groups by gender.
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Maximal oxygen consumption (ml·kg-1·min-1) increased 18.3 ± 13.2% and 20.2 ±13.5% for 
the 400 and 600 kcal/session groups, respectively and these changes were significantly 
different compared to the control group that declined -2.8 ± 5.6%. The change in maximal 
oxygen consumption was not significantly different between the exercise groups and was 
not significantly different between men and women for the 400 and 600 kcal/session groups 
and control group.
Energy intake/Physical Activity
There were no significant between group differences for energy intake (kcal/day) over the 
10 month intervention. Daily physical activity in the control group did not change over the 
10 month intervention. During the intervention, daily physical activity in both exercise 
groups was significantly greater than control; however, there were no significant differences 
between exercise groups.
Discussion
This study was designed and adequately powered to determine differences for weight 
change from baseline to 10 months between control and 2 levels of verified EEEx during an 
ad libitum diet. Exercise with EEEx of 400 or 600 kcal/session provided clinically 
meaningful weight loss (average 5%).11 When exercise is supervised and EEEx is of a 
sufficient magnitude, weight loss from exercise alone surpasses that observed in many very 
intense behavioral weight loss interventions using energy restriction20,21 and provides 
weight loss similar to the most successful interventions such as the Diabetes Prevention 
Program 22-24 without using energy restriction or intensive behavioral counseling. 
Moreover, weight loss with exercise, during ad libitum diet, was entirely due to loss in fat 
mass (100%). These results are comparable to previous exercise studies where fat mass 
decreased and lean mass remained unchanged or increased.19,25,26 In contrast, studies that 
use energy restriction and exercise for weight loss often observe reductions in lean mass that 
typically accounts for 22% to 30% of weight loss.27,28
Our results are in general agreement with the limited number of studies in individuals where 
exercise was verified, prescribed exercise by level of EEEx, and delivered in a dose 
sufficient to induce weight loss. For example, Ross et al.29 reported a mean weight loss of 
8% in 16 obese middle age men (~45 yrs.) who completed 700 kcal/day (70% peak VO2) 
treadmill exercise over 12 weeks. Ross et al.30 have shown similar results in a sample of 17 
obese post-menopausal women (~43 yrs) where a 14 week 500 kcal/day (80% maximal 
heart rate) aerobic exercise program resulted in a mean weigh loss of 6.8%. King et al.31 
reported a mean weight loss of 4.1% in a sample of overweight and obese middle-aged age 
(~30 yrs.) men (n = 10) and women (n = 25) who participated in a 12 week supervised 
exercise program with EEEx of 500 kcal/session, 5 days/week.
The literature on exercise level and weight loss is limited and results are mixed.32 For 
example, Jakicic et al.33 reported nearly identical and clinically non significant weight loss 
in a sample of predominantly women (~ 90%) who were randomly assigned to 18 months of 
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non-supervised aerobic exercise at 150 (-0.9%) or 300 minutes/week (-1.1%). Similar results 
were reported by Church et al.34 from a 6 month trial of supervised exercise (3-4 days/week, 
50% VO2 peak) at 4 kcal/kg/week (72 min), 8 kcal/kg/week (136 min) or 12 kcal·kg-1·wk-1 
(194 min). Weight loss in all the exercise groups was minimal and did not increase 
significantly with increased levels of exercise (4 kcal·kg-1·xwk-1 = -1.7%, 8 kcal·kg-1·wk-1 = 
-2.5%, 12 kcal·kg-1·wk-1 = -1.8%). These results are in contrast to those reported by both 
Slentz et al.35 and Irwin et al.36. For example, Slentz et al.35 completed a supervised 
exercise trial that compared weight loss between groups randomly assigned to either low (14 
kcal·kg-1·wk-1) or high (23 kcal·kg-1·wk-1) volume exercise at 65-85% peak VO2 (3.5 days/
week) over 8 months in middle aged to older (45-65 yrs) sedentary overweight men and 
women. Weight loss in the high volume group (-4.1%) was significantly greater than that 
observed in the low volume group (-1.3%). We ight loss data was not reported by gender, 
therefore it is not possible to determine if there was an effect of gender on the dose-response 
association.
No significant gender differences for weight loss at equivalent levels of EEEx were 
observed in the current study. This is in contrast to the results from our previous exercise 
trial (MET-1) where exercise was prescribed by frequency, intensity and duration which 
resulted in higher levels of EEEx and weight loss for men compared to women as a function 
of differences in body weight.19 Taken together, the results from MET-1 and the current 
study (MET-2) demonstrate the importance of prescribing exercise by level of EEEx when 
addressing questions relative to the impact of exercise on gender responses for body weight 
and composition. We are aware of only one additional report on gender differences for 
weight loss in response to exercise without energy restriction. After completing a 12 month 
program of aerobic exercise, Stefanick et al.37) reported similar and non-significant weight 
loss for both men (-0.6 kg, 0.7%) and women (-0.4 kg, 0.6%). However, the exercise 
program employed by Stefanick et al.37 was only partially supervised, prescribed by 
distance walked/jogged (10 miles/week), and compliance with the exercise protocol 
inadequately documented; thus, the results should be interpreted cautiously.
A high level of individual variability in weight change was observed in both the 400 and 600 
kcal/session within the groups (Figure 2) even though the level of EEEx was tightly 
controlled. Inherent inter-individual genetic differences in the weight response to exercise 
would be expected. However, the high degree of inter-individual variability in weight 
change suggests compensation in components of energy balance. Further work is warranted 
to identify the sources of compensation in both behavioral (i.e., energy intake, physical 
activity) and physiologic parameters (i.e., resting metabolic rate, appetite hormones) which 
might be potentially be modified to improve the efficacy of the use of exercise for targeted 
weight management interventions.
Strengths of the current investigation include supervised exercise prescribed by level of 
EEEx rather than frequency, intensity, and duration, and delivery of EEEx with a high level 
of precision (± 1% of target). The design of the study clearly illustrates the influence of the 
method of exercise prescription on outcomes of weight. To our knowledge, this is the only 
study to have a priori designed tests examining the equivalence of weight loss between men 
and women for varying exercise regimens. Limitations of this study may include the rate of 
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attrition (34.8%). However, we emphasize that MET-2 was an efficacy study designed to 
answer questions relative to the effect of exercise when completed as intended, and not 
designed to answer questions if exercise is completed as intended (i.e., effectiveness). 
Efficacy studies generally have higher attrition compared to effectiveness trials. We 
projected an overall attrition of 33% in our power calculations and the actual rate was 
34.8%. The current study design included strict protocol requirements for compliance. In 
addition to participant attrition, we also dismissed individuals that fell below the compliance 
criteria. The attrition rate is not unlike other weight loss studies found in the literature. For 
example, the attrition rate in a 16 week clinic-based weight loss program in 866 individuals 
was 31%.38 Another weight loss program in nearly 1800 people across 23 medical centers 
observed an attrition rate of 52% at 12 months.39 Additionally, due to the inclusion criteria 
(age, BMI) caution should be used for projecting these results to other populations. Lastly, 
the magnitude of weight loss may not generalize to studies that use intent to treat designs 
where compliance is not a criteria for inclusion in analysis and weight loss is generally 
lower compared to the current study.20,23,24
Summary
EEEx at 400 or 600 kcal/session resulted in a significant reduction in weight compared to 
controls. The average weight loss of 5% was due to reductions in fat mass and these 
reductions are known to provide improvements in chronic disease risk factors. Prescription 
of exercise using EEEx rather than frequency, intensity and duration resulted in similar 
weight loss for men and women in both exercise groups. Absence of a significant increase in 
weight loss between the 400 and 600 kcal/session groups suggests compensation in 
components of energy balance and warrants additional investigation that could lead to 
targeted interventions. When weight and gender are variables of interest, we recommend 
that exercise be prescribed using EEEx.
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Individual weight change percent by group and gender
Donnelly et al. Page 13














Body composition change percent by group and gender. * Indicates significantly different 
from control group.
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Individual weight change percent by group
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Table 1
Ten month exercise progression by group kcal/session and exercise intensity
Baseline characteristics for completers by group and gender (N = 92)
Month
400 kcal 600 kcal % heart rate maximum (days/week)
kcal/session kcal/session
1 150-175 150-250 70% (5)
2 200-225 275-375 70% (4) / 80% (1)
3 250-325 400-500 70% (3) / 80% (2)
4 350-400 525-600 70% (0-2) / 80% (3-5)
5-10 400 600 70% (0-1) / 80% (4-5)
Note. Ten month exercise progression by group and exercise intensity (days/week). For example, in month 2 there were five days of exercise with 
four exercise sessions completed at 70% and 1 exercise session completed at 80% of heart rate maximum.
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Table 3
Change in weight, BMI, body composition and aerobic capacity by group and gender
Change in weight, BMI, body composition and aerobic capacity by group and gender.
Variable Baseline 10 Month Change Group Difference




    Control 87.4 (14.6) 88.0 (15.8) 0.5 (-1.2, 2.3)
        Male 96.2 (11.1) 96.7 (12.5) 0.6 (-1.3, 2.5)
        Female 78.7 (12.6) 79.2 (14.1) 0.5 (-3.0, 3.9)
    400 kcal 91.4 (20.7) 87.4 (20.2) -3.9 (-5.6, -2.3)
        Male 99.9 (19.4) 96.1 (19.0) -3.8 (-6.6, -0.9)
        Female 83.3 (18.9) 79.2 (18.1) -4.1 (-6.1, -2.0)
    600 kcal 92.0 (16.1) 86.8 (16.6) -5.2 (-7.0, -3.3 )
        Male 102.0 (11.7) 96.2 (14.2) -5.9 (-9.1, -2.7)
        Female 81.3 (13.0) 76.9 (12.8) -4.4 (-6.5, -2.3)
BMI (kgm2) 0.0007
ab
    Control 29.7 (3.8) 29.9 (4.4) 0.2 (-0.5, 0.8)
        Male 30.6 (4.2) 30.7 (4.4) 0.2 (-0.4, 0.8)
        Female 28.9 (3.4) 29.1 (4.4) 0.2 (-1.1, 1.5)
    400 kcal 31.2 (5.6) 29.8 (5.5) -1.4 (-1.9, -0.8)
        Male 32.0 (5.5) 30.8 (5.5) -1.2 (-2.1, -0.3)
        Female 30.4 (5.6) 28.9 (5.4) -1.5 (-2.2, -0.8)
    600 kcal 30.6 (3.9) 28.9 (4.2) -1.7 (-2.3, -1.1)
        Male 32.1 (3.5) 30.2 (4.3) -1.9 (-2.9, -0.9)




    Control 41.0 (6.1) 40.4 (7.2) -0.6 (-1.7, 0.6)
        Male 36.9 (4.4) 35.8 (5.6) -1.1 (-2.6, 0.5)
        Female 45.1 (4.6) 45.0 (5.5) -0.1 (-2.1, 2.0)
    400 kcal 39.6 (7.5) 36.6 (8.3) -2.9 (-4.3, -1.6)
        Male 35.4 (6.8) 32.8 (7.5) -2.7 (-4.9, -0.4)
        Female 43.6 (5.8) 40.5 (7.3) -3.2 (-4.9, -1.6)
    600 kcal 40.2 (6.2) 35.9 (7.6) -4.3 (-5.8, -2.8)
        Male 37.0 (5.0) 32.5 (6.8) -4.5 (-6.9, -2.2)




    Control 34.1 (7.7) 34.2 (9.1) 0.2 (-1.4, 1.7)
        Male 34.1 (7.9) 34.0 (9.5) -0.1 (-2.6, 2.4)
        Female 34.1 (7.8) 34.5 (9.2) 0.4 (-2.1, 2.9.)
    400 kcal 34.6 (11.2) 31.3 (11.6) -3.5 (-5.1, -1.8)
        Male 34.5 (11.6) 31.0 (11.4) -3.6 (-6.2, -0.9)
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Variable Baseline 10 Month Change Group Difference
Mean (SD) Mean (SD) Mean (95% CI) p-value
        Female 34.8 (11.1) 31.7 (12.2) -3.4 (-5.7, -1.1)
    600 kcal 35.3 (8.4) 30.1 (9.7) -5.2 (-6.9, -3.4)
        Male 36.4 (7.5) 30.5 (10.1) -5.9 (-8.8, -3.0)
        Female 34.1 (9.4) 29.7 (9.6) -4.4 (-6.6, -2.3)
Fat free mass (kg) 0.0733
    Control 52.1 (10.1) 53.3 (11.5) 1.2 (0.2, 2.1)
        Male 60.7 (5.0) 62.8 (6.2) 2.1 (0.8, 3.3)
        Female 43.5 (5.1) 43.7 (6.3) 0.3 (-1.2, 1.7)
    400 kcal 55.7 (12.5) 55.7 (12.1) 0.0 (-0.6, 0.7)
        Male 64.4 (9.9) 64.4 (9.2) 0.0 (-1.0, 1.0)
        Female 46.9 (8.0) 47.0 (7.7) 0.1 (-0.7, 0.9)
    600 kcal 55.8 (11.5) 56.4 (11.2) 0.6 (0.1, 1.1)
        Male 65.0 (7.3) 65.4 (7.4) 0.4 (-0.4, 1.2)
        Female 46.1 (5.3) 46.9 (4.8) 0.8 (0.2, 1.5)
VO2 (ml·kg-1·min-1) <0.0001
ab
    Control 32.3 (5.0) 31.4 (5.3) -0.9 (-1.9, 0.1)
        Male 34.3 (5.8) 33.0 (6.4) -1.3 (-3.2, 0.5)
        Female 30.2 (3.3) 29.8 (3.7) -0.4 (-1.6, 0.7)
    400 kcal 33.4 (6.5) 39.4 (7.9) 5.9 (4.6, 7.2)
        Male 37.1 (6.5) 42.9 (8.0) 5.8 (4.2, 7.3)
        Female 29.8 (4.1) 35.9 (6.2) 6.1 (3.8, 8.3)
    600 kcal 34.1 (5.7) 40.8 (7.2) 6.7 (5.3, 8.1)
        Male 36.4 (6.4) 44.2 (7.6) 7.8 (5.4, 10.2)
        Female 31.6 (3.8) 37.2 (4.7) 5.6 (4.2, 7.1)
VO2 (L·min-1) <0.0001
ab
    Control 2.8 (0.6) 2.7 (0.5) -0.1 (-0.1, 0.0 )
        Male 3.2 (0.4) 3.1 (0.4) -0.1 (-0.2, 0.0)
        Female 2.4 (0.2) 2.3 (0.3) -0.0 (-0.1, 0.1)
    400 kcal 3.0 (0.7) 3.4 (0.8) 0.3 (0.2, 0.4)
        Male 3.6 (0.5) 4.0 (0.5) 0.4 (0.3, 0.5)
        Female 2.5 (0.4) 2.7 (0.5) 0.2 (0.0, 0.5)
    600 kcal 3.1 (0.8) 3.5 (0.9) 0.4 (0.3, 0.5)
        Male 3.7 (0.7) 4.2 (0.7) 0.6 (0.4, 0.7)
        Female 2.5 (0.3) 2.8 (0.3) 0.3 (0.2, 0.4)
Note.
a
Indicates 400 kcal/session group differs from control group.
b
Indicates 600 kcal/session group differs from control group. 400 kcal/session and 600 kcal/session were not different (all p > 0.05). No gender 
effect or group-gender interaction (all p > 0.05).
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